These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 849874

  • 1. The activation mechanism of the alternative pathway of the human complement system by the immune precipitate formed with F(ab')2 of rabbit IgG antibody: the generation of C3- and C5-cleaving enzymes on the immune precipitate.
    Fujita T, Takiuchi M, Iida K, Nagaki K, Inai S.
    Immunochemistry; 1977 Jan; 14(1):25-30. PubMed ID: 849874
    [No Abstract] [Full Text] [Related]

  • 2. The activation mechanism of human complement system by immune precipitate formed with rabbit IgG antibody.
    Fujita T.
    Microbiol Immunol; 1979 Jan; 23(10):1023-31. PubMed ID: 514094
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Importance of the integrity of the inter-heavy-chain disulphide bond of rabbit IgG in the activation of the alternative pathway of human complement by the F(ab')2 region of rabbit IgG antibody in immune aggregates.
    Gadd KJ, Reid KB.
    Immunology; 1981 Jan; 42(1):75-82. PubMed ID: 6780451
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of injury of virus-infected cells by antiviral antibody and complement: participation of IgG, F(ab')2, and the alternative complement pathway.
    Perrin LH, Joseph BS, Cooper NR, Oldstone MB.
    J Exp Med; 1976 May 01; 143(5):1027-41. PubMed ID: 177712
    [Abstract] [Full Text] [Related]

  • 10. Human monocyte spreading induced by activated factor B of the complement alternative pathway: differential effects of Fab' and F(ab')2 antibody fragments directed to C5, C6, and C7.
    Sundsmo JS, Götze O.
    Cell Immunol; 1983 Apr 01; 77(1):176-86. PubMed ID: 6601526
    [Abstract] [Full Text] [Related]

  • 11. Complement activity in normal rabbit bronchoalveolar fluid. Description of an inhibitor of C3 activation.
    Giclas PC, King TE, Baker SL, Russo J, Henson PM.
    Am Rev Respir Dis; 1987 Feb 01; 135(2):403-11. PubMed ID: 3643768
    [Abstract] [Full Text] [Related]

  • 12. The reactivity of the complement system.
    Hadding U.
    Monogr Allergy; 1977 Feb 01; 12():36-45. PubMed ID: 335218
    [No Abstract] [Full Text] [Related]

  • 13. The alternative pathway of complement activation.
    Götze O, Müller-Eberhard HJ.
    Adv Immunol; 1976 Feb 01; 24():1-35. PubMed ID: 798473
    [No Abstract] [Full Text] [Related]

  • 14. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
    Medicus RG, Götze O, Müller-Eberhard HJ.
    J Exp Med; 1976 Oct 01; 144(4):1076-93. PubMed ID: 978134
    [Abstract] [Full Text] [Related]

  • 15. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
    Antón LC, Alcolea JM, Sánchez-Corral P, Marqués G, Sánchez A, Vivanco F.
    Biochem J; 1989 Feb 01; 257(3):831-8. PubMed ID: 2784671
    [Abstract] [Full Text] [Related]

  • 16. Relative inefficiency of terminal complement activation.
    Bhakdi S, Fassbender W, Hugo F, Carreno MP, Berstecher C, Malasit P, Kazatchkine MD.
    J Immunol; 1988 Nov 01; 141(9):3117-22. PubMed ID: 3262681
    [Abstract] [Full Text] [Related]

  • 17. Metabolism of the fifth component of complement, and its relation to metabolism of the third component, in patients with complement activation.
    Sissons JG, Liebowitch J, Amos N, Peters DK.
    J Clin Invest; 1977 Apr 01; 59(4):704-15. PubMed ID: 845257
    [Abstract] [Full Text] [Related]

  • 18. C3 requirements for formation of alternative pathway C5 convertase.
    Daha MR, Fearon DT, Austen KF.
    J Immunol; 1976 Aug 01; 117(2):630-4. PubMed ID: 950465
    [Abstract] [Full Text] [Related]

  • 19. [Complement activation and biological activities].
    Inoue K.
    Nihon Saikingaku Zasshi; 1976 Jul 01; 31(4):535-55. PubMed ID: 988219
    [No Abstract] [Full Text] [Related]

  • 20. Effects of granulocyte neutral proteases on complement components.
    Johnson U, Ohlsson K, Olsson I.
    Scand J Immunol; 1976 Jul 01; 5(4):421-6. PubMed ID: 181839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.